Değer M.D.a· Madendere S.b· Öztekin Ç.V.c

Author affiliations

aDepartment of Urology, Edirne Sultan 1st Murat State Hospital, Edirne, Turkey
bDepartment of Urology, Çorlu State Hospital, Çorlu, Turkey
cDepartment of Urology, Near East University, Nicosia, Cyprus

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply

Start free trial

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

Received: October 15, 2022
Accepted: January 04, 2023
Published online: April 20, 2023

Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 2

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Introduction: Using Google Trends (GT) data, the trend variations for the most common antibiotics used to treat uncomplicated cystitis were analyzed by time and region since 2004. Methods: GT was used to create a “line-graph” that shows how interest in a topic in certain locations has grown or decreased over time. The relative search volume, which is displayed on a scale of 0–100, was used to index the search values for specific phrases. Nitrofurantoin (NFN), fosfomycin (FOS), trimethoprim (TMP), pivmecillinam (PIV), and cefadroxil are among the antibiotics recommended by the European Association of Urology (EAU) and the American Urological Association for the treatment of uncomplicated cystitis. Using the “global” inquiry category, the data was searched “worldwide” from 1 February 2004 to 31 December 2021. Results: In the regression analysis, all antibiotics exhibited positive trends (p < 0.05). With a steady rise in popularity, NFN is the most popular antibiotic today. Search trend for cefadroxil stayed nearly stable until 2012, the rate of rise in the last 10 years increased, and cefadroxil is the second most popular antibiotic. In the previous 5 years, there was a decline in interest in TMP. In recent years, there was an increase in the trends for FOS and PIV. Conclusion: Clinicians and patients all around the world increasingly use the web to search for antibiotic therapies for uncomplicated cystitis. Antibiotics used to treat uncomplicated cystitis have various trends in different continents throughout the world. The web trends seem to be compatible with daily use.

© 2023 S. Karger AG, Basel

References EAU guidelines on urological infections. Presented at the EAU Annual Congress. Amsterdam, the Netherlands; 2022. Arnhem, the Netherlands: EAU Guidelines Office; 2022. https://uroweb.org/guidelines/urological-infections/summary-of-changes. Naber KG, Bonkat G, Wagenlehner FME. The EAU and AUA/CUA/SUFU guidelines on recurrent urinary tract infections: what is the difference?Eur Urol. 2020 Nov;78(5):645–6. Mulder M, Baan E, Verbon A, Stricker B, Verhamme K. Trends of prescribing antimicrobial drugs for urinary tract infections in primary care in The Netherlands: a population-based cohort study. BMJ Open. 2019;9(5):e027221. Galatti L, Sessa A, Mazzaglia G, Pecchioli S, Rossi A, Cricelli C, et al. Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study. J Antimicrob Chemother. 2006;57(3):551–6. Değer MD, Madendere S. Erectile dysfunction treatment with Phosphodiesterase-5 Inhibitors: google trends analysis of last 10 years and COVID-19 pandemic. Arch Ital Urol Androl. 2021;93(3):361–5. Madendere S, Değer MD, Aktoz T. Global web trends analysis of minimally invasive urinary stone treatment in the last decade and during the COVID-19 pandemic. J Endourol. 2022 Oct;36(10):1271–6. Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463–70. Kusama Y, Ishikane M, Kihara T, Ohmagari N. Epidemiology of antibiotic treatment for uncomplicated cystitis in adults in Japan. J Infect Chemother. 2021;27(1):113–6. Li X, Sundquist K, Jansåker F. Fluoroquinolones and other antibiotics redeemed for cystitis-A Swedish nationwide cohort follow-up study (2006–2018). Antibiotics. 2022;11(2):172. Wagenlehner FME, Wullt B, Perletti G. Antimicrobials in urogenital infections. Int J Antimicrob Agents. 2011;38(Suppl l):3–10. Wagenlehner FME, Hoyme U, Kaase M, Fünfstück R, Naber KG, Schmiemann G. Uncomplicated urinary tract infections. Dtsch Arztebl Int. 2011;108(24):415–23. de Cueto M, Aliaga L, Alós JI, Canut A, Los-Arcos I, Martínez JA, et al. Executive summary of the diagnosis and treatment of urinary tract infection: guidelines of the Spanish society of clinical microbiology and infectious diseases (SEIMC). Enferm Infecc Microbiol Clin. 2017;35(5):314–20. Aguinaga A, Gil-Setas A, Mazón Ramos A, Alvaro A, García-Irure JJ, Navascues A, et al. Uncomplicated urinary tract infections. Antimicrobial susceptibility study in Navarre. An Sist Sanit Navar. 2018;41(1):17–26. Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother. 2015;70(9):2456–64. Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med. 2007;167(20):2207–12. Gupta K, Grigoryan L, Trautner B. Urinary tract infection. Ann Intern Med. 2017;167(7):Itc49–64. Ternes B, Wagenlehner FME. Guideline-based treatment of urinary tract infections. Urologe A. 2020;59(5):550–8. Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243–62. Vik I, Bollestad M, Grude N, Bærheim A, Damsgaard E, Neumark T, et al. Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial. PLoS Med. 2018;15(5):e1002569. Hooton TM, Roberts PL, Stapleton AE. Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. Jama. 2012;307(6):583–9. Gaitonde S, Malik RD, Zimmern PE. Financial burden of recurrent urinary tract infections in women: a time-driven activity-based cost analysis. Urology. 2019;128:47–54. Khosla L, Bockelman D, Gong S, Vizgan G, Kabarriti AE. Impact of COVID-19 on online interest in urologic conditions: an analysis of google trends. Cureus. 2022;14(1):e21149. Rossignol L, Pelat C, Lambert B, Flahault A, Chartier-Kastler E, Hanslik T. A method to assess seasonality of urinary tract infections based on medication sales and google trends. PLoS One. 2013;8(10):e76020. Beck F, Richard JB, Nguyen-Thanh V, Montagni I, Parizot I, Renahy E. Use of the internet as a health information resource among French young adults: results from a nationally representative survey. J Med Internet Res. 2014 May 13;16(5):e128. Article / Publication Details

Received: October 15, 2022
Accepted: January 04, 2023
Published online: April 20, 2023

Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 2

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.